Early Safety Assessment - Drug Discovery and Development Based on

The drug candidate faces numerous efficacy and safety hurdles before moving forward to clinical testing. Here at the UPDDI we recognize the need for early identification of potential human toxicity and pharmacokinetic issues by creating a unique human liver microphysiological systems  platform for drug testing before implementing preclinical animal testing.

Target Product Profiling & Drug Safety Assessment - SciLifeLab

Why 90% of clinical drug development fails and how to improve it

Principles of early drug discovery - Hughes - 2011 - British

Which Human Metabolites Have We MIST? Retrospective Analysis

Drug development – The four phases - BioStock

PDF) Investigative safety strategies to improve success in drug

Label-free drug discovery strategy. Combining computational

Early Safety Assessment - Drug Discovery and Development Based on

Preclinical Working Group National Institutes of Health (NIH)